Intima media thickness of common carotid arteries is associated with traditional risk factors and presence of ischaemic heart disease in hemodialysis patients.

Patients with chronic renal failure are prone to cardiovascular complications. The mechanisms and the assessment of the risk of cardiovascular diseases (CVD) in this population are of interest. The purpose of this study was to investigate the traditional and potential risk factors for the development of CVD and their contribution to ischemic heart disease (IHD) and variation in carotid intima media thickness (IMT) in hemodialyzed patients (HD). Twenty-one chronically HD patients and nineteen healthy volunteers were recruited. Studied parameters were intima-media thickness, body mass index (BMI), mean arterial blood pressure (MAP), hemoglobin, fibrinogen (Fbg), serum lipids, lipoprotein (a) [Lp(a)], total homocysteine (tHcy). Mean carotid IMT, tHcy, Fbg and Lp(a) were higher in HD patients compared to the control group. There were no differences in cholesterol (tCh) and triglycerides between these groups. Patients with ischemic heart disease were older and they had higher values of carotid IMT, tCh, triglycerides, Fbg and Lp(a). There were no differences in MAP, time on dialysis and tHcy between the two subgroups (with vs without IHD). Carotid IMT correlated positively with age (r = 0.68, p = 0.001), BMI (r = 0.50, p = 0.02), tCh (r = 0.58, p < 0.01), LDL- cholesterol (r = 0.55, p = 0.01) and Fbg (r = 0.57, p < 0.01) but not with tHcy or Lp(a) in the patients group. Carotid intima media thickness thus reflects the risk for ischemic heart disease in hemodialyzed patients. Elevated fibrinogen concentration and dyslipidemia influence arterial remodelling.

[1]  F. Locatelli,et al.  Hypertension and cardiovascular risk assessment in dialysis patients. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  L. Iacoviello,et al.  Homocysteinemia in patients with type 1 diabetes in relation to renal function. , 2001, Diabetes Care.

[3]  J. Małyszko,et al.  Correlation between carotid intima–media thickness and hematocrit and hemoglobin values in renal transplant recipients , 2001, Clinical transplantation.

[4]  G. London,et al.  Cardiovascular risk in end-stage renal disease: vascular aspects. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  D. Wilcken,et al.  Homocysteine and cardiovascular disease: cause or effect? , 2000, The American journal of clinical nutrition.

[6]  Colin Baigent,et al.  Premature cardiovascular disease in chronic renal failure , 2000, The Lancet.

[7]  Mohamed,et al.  Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients. , 2000, Kidney international.

[8]  J. Spence,et al.  Validation of an enzyme immunoassay for the determination of total homocysteine in plasma. , 2000, Blood Coagulation and Fibrinolysis.

[9]  C. Zoccali Cardiovascular risk in uraemic patients-is it fully explained by classical risk factors? , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  H. Makino,et al.  The Significance of Atherogenic Indices in Patients on Hemodialysis , 2000, American Journal of Nephrology.

[11]  H. Philippou,et al.  Relationships between homocysteine, factor VIIa, and thrombin generation in acute coronary syndromes. , 2000, Circulation.

[12]  K. Harjai Potential New Cardiovascular Risk Factors: Left Ventricular Hypertrophy, Homocysteine, Lipoprotein(a), Triglycerides, Oxidative Stress, and Fibrinogen , 1999, Annals of Internal Medicine.

[13]  S. Nishi,et al.  Lipoprotein(a) is a predictor for cardiovascular mortality of hemodialysis patients. , 1999, Kidney international. Supplement.

[14]  M. Schreiber,et al.  Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis. , 1999, Kidney international.

[15]  A. Levey,et al.  Epidemiology of Cardiac Disease in Dialysis Patients , 1999 .

[16]  C. Berne,et al.  Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. , 1999, Kidney international.

[17]  A. Hofman,et al.  Cross‐sectionally assessed carotid intima–media thickness relates to long‐term risk of stroke, coronary heart disease and death as estimated by available risk functions , 1999, Journal of internal medicine.

[18]  S. Sirrs,et al.  Homocyst(e)ine and vascular access complications in haemodialysis patients: insights into a complex metabolic relationship. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  R. Krauss,et al.  Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. , 1999, Circulation.

[20]  R. Kronmal,et al.  Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. , 1999, The New England journal of medicine.

[21]  G. Boers,et al.  Carotid and femoral artery wall thickness and stiffness in patients at risk for cardiovascular disease, with special emphasis on hyperhomocysteinemia. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[22]  E. Ritz,et al.  Apolipoprotein A, fibrinogen, age, and history of stroke are predictors of death in dialysed diabetic patients: a prospective study in 412 subjects. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  I. Rosenberg,et al.  Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[24]  A. Folsom,et al.  Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. , 1997, American journal of epidemiology.

[25]  T. Shoji,et al.  High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. , 1995, Kidney international.

[26]  P. Ridker,et al.  Plasma concentration of lipoprotein(a) and the risk of future stroke. , 1995, JAMA.

[27]  D. Grobbee,et al.  Carotid artery intima‐media thickness as an indicator of generalized atherosclerosis , 1994, Journal of internal medicine.

[28]  P. Ridker,et al.  A prospective study of lipoprotein(a) and the risk of myocardial infarction. , 1993, JAMA.

[29]  W. Koenig,et al.  The possible role of hemorheology in atherothrombogenesis. , 1992, Atherosclerosis.

[30]  E G Lowrie,et al.  Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[31]  S. Rostand,et al.  Dialysis-associated ischemic heart disease: insights from coronary angiography. , 1984, Kidney international.

[32]  Eary,et al.  CAROTID-ARTERY INTIMA AND MEDIA THICKNESS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND STROKE IN OLDER ADULTS , 2000 .

[33]  A. Donker,et al.  No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[34]  F. Kronenberg,et al.  Lipoprotein(a) in renal disease. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[35]  W Riley,et al.  Risk factors and segment-specific carotid arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) cohort. , 1996, Stroke.

[36]  S. Thompson,et al.  Haemostatic function and cardiovascular death: early results of a prospective study. , 1980, Lancet.